Galectin Therapeutics (GALT) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.16% |
| Dec 31, 2025 | -2.09% |
| Sep 30, 2025 | -5.39% |
| Jun 30, 2025 | -4.30% |
| Mar 31, 2025 | -8.77% |
| Dec 31, 2024 | -11.24% |
| Sep 30, 2024 | -12.32% |
| Jun 30, 2024 | -89.03% |
| Mar 31, 2024 | 28.40% |
| Dec 31, 2023 | -17.81% |
| Sep 30, 2023 | 0.48% |
| Jun 30, 2023 | -19.11% |
| Mar 31, 2023 | -30.82% |
| Dec 31, 2022 | -40.98% |
| Sep 30, 2022 | -41.97% |
| Jun 30, 2022 | -114.07% |
| Mar 31, 2022 | -986.45% |
| Dec 31, 2021 | -88.13% |
| Sep 30, 2021 | -51.11% |
| Jun 30, 2021 | -6.77% |
| Mar 31, 2021 | -26.52% |
| Dec 31, 2020 | -24.65% |
| Sep 30, 2020 | -15.50% |
| Jun 30, 2020 | -13.99% |
| Mar 31, 2020 | -6.48% |
| Dec 31, 2019 | -8.14% |
| Sep 30, 2019 | -4.29% |
| Jun 30, 2019 | 874.76% |
| Mar 31, 2019 | -1.08% |
| Dec 31, 2018 | -28.57% |
| Sep 30, 2018 | -10.02% |
| Jun 30, 2018 | 770.49% |
| Mar 31, 2018 | 274.53% |
| Dec 31, 2017 | -155.97% |
| Sep 30, 2017 | -76.87% |
| Jun 30, 2017 | -48.26% |
| Mar 31, 2017 | -23.12% |
| Dec 31, 2016 | -0.13% |
| Sep 30, 2016 | 37.64% |
| Jun 30, 2016 | -39.97% |
| Mar 31, 2016 | -30.86% |
| Dec 31, 2015 | 40.55% |
| Sep 30, 2015 | -28.20% |
| Jun 30, 2015 | -18.17% |
| Mar 31, 2015 | 3.08% |
| Dec 31, 2014 | -8.71% |
| Sep 30, 2014 | -9.75% |
| Jun 30, 2014 | -8.99% |
| Mar 31, 2014 | 1,808.58% |
| Dec 31, 2013 | 13.92% |
| Sep 30, 2013 | 142.08% |
| Jun 30, 2013 | -198.17% |
| Mar 31, 2013 | -188.93% |
| Dec 31, 2012 | -61.89% |
| Sep 30, 2012 | -37.69% |
| Jun 30, 2012 | -28.11% |
| Mar 31, 2012 | 421.13% |
| Dec 31, 2011 | -358.20% |
| Sep 30, 2011 | -10.05% |